Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

NCT00679939 PHASE4 COMPLETED Results posted

The purpose of this study is to determine the effects of rosiglitazone on the bone in postmenopausal women with type 2 diabetes mellitus

Details

Lead sponsor	GlaxoSmithKline
Phase	PHASE4
Status	COMPLETED
Enrolment	226
Start date	Mon Apr 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Sep 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Diabetes Mellitus, Type 2

Interventions

• Rosiglitazone
• Metformin

Countries

Pakistan, Estonia, Mexico, Philippines, Argentina, Canada, United States, Spain